Spineway (ALSPW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Spineway (ALSPW) has a cash flow conversion efficiency ratio of 0.023x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€538.00K ≈ $628.98K USD) by net assets (€23.86 Million ≈ $27.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Spineway fund operations to measure how many days the company can operate on defensive assets alone.
Spineway - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Spineway's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Spineway Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Spineway ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
QX Resources Ltd
AU:QXR
|
-0.084x |
|
My Rewards International Ltd
AU:MRI
|
0.003x |
|
INTL SCHOOL AUGS.AG NA ON
F:9JK
|
N/A |
|
DSS Inc
NYSE MKT:DSS
|
-0.290x |
|
CAQ Holdings Ltd
AU:CAQ
|
-0.001x |
|
Reklaim Ltd
V:MYID
|
-0.299x |
|
Rayong Wire Industries Public Company Limited
BK:RWI
|
-0.006x |
|
Lucapa Diamond Company Ltd
AU:LOM
|
-0.039x |
Annual Cash Flow Conversion Efficiency for Spineway (2011–2025)
The table below shows the annual cash flow conversion efficiency of Spineway from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Spineway market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €23.06 Million ≈ $26.96 Million |
€-163.00K ≈ $-190.56K |
-0.007x | +94.77% |
| 2024-12-31 | €24.24 Million ≈ $28.34 Million |
€-3.27 Million ≈ $-3.83 Million |
-0.135x | +55.85% |
| 2023-12-31 | €19.05 Million ≈ $22.28 Million |
€-5.83 Million ≈ $-6.81 Million |
-0.306x | -315.53% |
| 2022-12-31 | €22.01 Million ≈ $25.73 Million |
€-1.62 Million ≈ $-1.89 Million |
-0.074x | +14.38% |
| 2021-12-31 | €20.88 Million ≈ $24.41 Million |
€-1.79 Million ≈ $-2.10 Million |
-0.086x | -111.09% |
| 2020-12-31 | €10.02 Million ≈ $11.71 Million |
€-408.00K ≈ $-476.99K |
-0.041x | +77.22% |
| 2019-12-31 | €6.49 Million ≈ $7.59 Million |
€-1.16 Million ≈ $-1.36 Million |
-0.179x | +95.04% |
| 2018-12-31 | €945.00K ≈ $1.10 Million |
€-3.41 Million ≈ $-3.99 Million |
-3.608x | -593.91% |
| 2017-12-31 | €1.77 Million ≈ $2.07 Million |
€-922.00K ≈ $-1.08 Million |
-0.520x | -241.43% |
| 2016-12-31 | €1.30 Million ≈ $1.52 Million |
€-198.00K ≈ $-231.48K |
-0.152x | -364.80% |
| 2015-12-31 | €3.02 Million ≈ $3.53 Million |
€-99.00K ≈ $-115.74K |
-0.033x | +91.21% |
| 2014-12-31 | €4.62 Million ≈ $5.41 Million |
€-1.72 Million ≈ $-2.01 Million |
-0.373x | -68.98% |
| 2013-12-31 | €5.12 Million ≈ $5.99 Million |
€-1.13 Million ≈ $-1.32 Million |
-0.221x | -167.96% |
| 2012-12-31 | €1.16 Million ≈ $1.36 Million |
€378.00K ≈ $441.92K |
0.324x | +172.35% |
| 2011-12-31 | €844.99K ≈ $987.88K |
€-379.00K ≈ $-443.09K |
-0.449x | -- |
About Spineway
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more